Navigation Links
Joseph J. Ross, M.D., F.A.C.S. Joins Stem Cell Assurance as Vice Chairman

BOCA RATON, Fla., March 11 /PRNewswire-FirstCall/ -- Stem Cell Assurance, Inc. (Pink Sheets: SCLZ) Stem Cell Assurance is pleased to announce the inclusion of one of the Cleveland Clinic's 2010 Best Doctors, Dr. Joseph J. Ross, M.D., F.A.C.S.  Dr. Ross will officially take up Vice Chairmanship for the company in March 2010.  Stem Cell Assurance welcomes his appointment to strengthen operations of their national physician network designed to provide medical and cosmetic procedures and cell banking to individual clients.  This latest development for Stem Cell Assurance follows the company's exponential growth in practice locations with the addition of many industry-leading physicians.    

Dr. Ross's experience makes him ideally placed to assume a central role within Stem Cell Assurance.  He currently holds professional positions at Envision Eye Specialists in Crystal River, Florida and The Omni Eye Institute in Ocala, Florida and is licensed in the states of Ohio, Arizona, and Florida.  He obtained his medical degree from Case Western Reserve University School of Medicine in Cleveland, Ohio and completed a fellowship in ophthalmic and facial cosmetic and reconstructive plastic surgery at the University of Arizona under renowned Preceptor Robert M. Dryden, M.D.  

Dr. Ross is board certified in ophthalmology.  He is a fellow of the American Academy of Facial Plastic Surgeons, the American Society of Ophthalmic Plastic and Reconstructive Surgeons, the American College of Surgeons, the Ohio State Medical Society, and the Florida Medical Association, among six other major memberships.  He is currently the Director of Oculoplastics Service at MetroHealth Medical Center in Cleveland, Ohio and Assistant Clinical Professor in the Department of Dermatology at Case Western Reserve University School of Medicine.    

Dr. Ross has authored publications on topics including cancer, facial contouring, dermal fat grafts, and facial implants.  His work has been included in major publications including The Journal of Dermatologic Surgery and Oncology and Ophthalmic Plastic and Reconstructive Surgery.  He has presented and lectured extensively on such topics as plastic, cosmetic, and reconstructive surgery techniques and office procedures; skin cancer detection and management; facelifts; nose reconstruction; skin care including products, chemical peels, microdermabrasion, and lasers; and micrografting.

As the new Vice Chairman of Stem Cell Assurance, Dr. Ross commented "Stem Cell Assurance, which offers invaluable bioinsurance services through stem cell banking and other exciting cosmetic applications, dovetails perfectly with my feelings towards the potential of stem cells to discover better therapies and ultimately even cures for debilitating diseases.  Stem Cell Assurance is ready to monetize its extensive assets and deliver its branded services to clients and patients.  I am eager to come aboard as Vice Chairman at this time of great growth in the company, and I look forward to the road ahead."

About Stem Cell Assurance

Stem Cell Assurance, Inc. is the first company in the US to provide full-spectrum adult stem cell services to consumers through a national physician network.  The company offers genetic profiling services and consultation, adult stem cell research, and stem cell collection, processing, and cryogenic storage, as well as cosmetic and other infusion therapies.  The company is based in Boca Raton, Florida.  See for more information.

Investor Relations:

Equiti-Trend Advisors


SOURCE Stem Cell Assurance, Inc.

Back to top



SOURCE Stem Cell Assurance, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
2. SGX Pharmaceuticals Appoints Joseph L. Turner to Board of Directors
3. Dr. Joseph L. Corriveau Appointed Director of Research and Technology
4. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
5. Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBCs Drug Discovery & Development of Innovative Therapeutics Conference
6. Spherics, Inc. Assigns Assets to Joseph F. Finn, Jr., C.P.A.
7. WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
8. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
9. Board of Directors of Milestone Scientific Names Joseph DAgostino Chief Financial Officer
10. St. Josephs Hospital and Medical Center to Utilize Clinical InfoNET System for Physicians
11. PAREXEL Appoints Josephine Hoppe to Chief Information Officer
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 01, ... ... a leading relationship marketing company specializing in scientifically backed, age-defying products, is ... 2016 issue, which highlights the exponential success and unrivaled opportunities that Nerium ...
(Date:12/1/2015)... 1, 2015 Cepheid (Nasdaq: CPHD ) ... the Piper Jaffray Healthcare Conference in New ... is reaffirming its outlook for the fourth quarter of ... to discussing longer term business model expectations. ...  "We continue to be the fastest growing company of ...
(Date:12/1/2015)... Texas (PRWEB) , ... December 01, 2015 , ... ... annual global meeting this month and Dr. J. Kyle Mathews will ... This includes the new single site hysterectomy. , An experienced urogynecologist, founder of ...
(Date:12/1/2015)... 2015 ) ... U.K. Virology and Bacteriology Testing Market: Sales ... Supplier Shares by Test, Innovative Technologies, Competitive ... --> ) has announced ... and Bacteriology Testing Market: Sales and Volume ...
Breaking Biology Technology:
(Date:11/18/2015)... , Nov. 18, 2015  As new scientific ... children, doctors and other healthcare providers face challenges in ... families and patients. In addition, as more children continue ... a patient,s adulthood and old age. John ... The Children,s Hospital of Philadelphia (CHOP) . ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces ... joined its Board of Directors. --> ... after recently retiring from the partnership at TPG Capital, ... companies with over $140 Billion in revenue.  He founded ... across all the TPG companies, from 1997 to 2013.  ...
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has ... of MIT and Harvard for use of its ... information management tools. The partnership will support the ... biological and chemical research information internally and with ... be used for managing the Institute,s electronic laboratory ...
Breaking Biology News(10 mins):